{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:30:36Z","timestamp":1785526236140,"version":"3.56.0"},"reference-count":224,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["ATVB"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer survivors are at an increased risk for major adverse cardiovascular events and cardiovascular disease mortality compared with the general population. In fact, emerging evidence suggests that cardiovascular disease is the leading cause of mortality 10 years into survivorship for some cancer populations. While this heightened cardiovascular risk undoubtedly involves a variety of factors, antineoplastic therapies, such as anthracyclines, are known to contribute significantly to this pathology. As such, modalities that improve the localization of treatments to the tumor while simultaneously minimizing off-target effects on noncancerous cells are greatly needed. Approaches in which anthracyclines are injected directly into tumor-feeding arterioles (locoregional\/intra-arterial administration) or are encapsulated in tumor-directed nanoparticles have gained prominence in certain cancers. Such therapies should direct cardiotoxic chemotherapy away from sites of potential toxicity while leaving the tumor exposed. However, current clinical findings on the efficacy and cardiovascular safety of these treatments remain inconclusive, and their use for many cancers is limited. This narrative review aims to highlight current clinical findings that have evaluated the safety and efficacy of locoregional and nanoparticle-mediated anthracycline administration as they compare with systemic delivery and identify avenues to be explored by future research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1161\/atvbaha.125.319865","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T09:00:23Z","timestamp":1775120423000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity"],"prefix":"10.1161","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5942-5554","authenticated-orcid":true,"given":"Stephen T.","family":"Hammond","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Cardiovascular Research Center (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-4146","authenticated-orcid":true,"given":"Lukas","family":"Brandt","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Cardiovascular Research Center (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1864-7104","authenticated-orcid":true,"given":"Amanda L.","family":"Kong","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery (A.L.K.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"White","sequence":"additional","affiliation":[{"name":"Division of Vascular and Interventional Radiology, Department of Radiology (S.B.W.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Cardiovascular Research Center (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-7492","authenticated-orcid":true,"given":"Andreas M.","family":"Beyer","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Department of Physiology (A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Cardiovascular Research Center (S.T.H., L.B., D.L., A.M.B.), Medical College of Wisconsin, Milwaukee."},{"name":"Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio (A.M.B.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","first-page":"31","article-title":"Daunomycin: a new antibiotic with antitumor activity.","volume":"38","author":"Dimarco A","year":"1964","unstructured":"Dimarco A, Gaetani M, Dorigotti L, Soldati M, Bellini O. Daunomycin: a new antibiotic with antitumor activity. Cancer Chemother Rep. 1964;38:31\u201338.","journal-title":"Cancer Chemother Rep"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000507"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12030436"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199700544-00003"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.312395"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.93"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/030089160308900302"},{"key":"e_1_3_3_9_2","first-page":"229","article-title":"Pegylated liposomal doxorubicin in ovarian cancer.","volume":"1","author":"Green AE","year":"2006","unstructured":"Green AE, Rose PG. Pegylated liposomal doxorubicin in ovarian cancer. Int J Nanomedicine. 2006;1:229\u2013239.","journal-title":"Int J Nanomedicine"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00684887"},{"key":"e_1_3_3_11_2","first-page":"1221","article-title":"Doxorubicin distribution in human breast cancer.","volume":"71","author":"Rossi C","year":"1987","unstructured":"Rossi C, Gasparini G, Canobbio L, Galligioni E, Volpe R, Candiani E, Toffoli G, D\u2019Incalci M. Doxorubicin distribution in human breast cancer. Cancer Treat Rep. 1987;71:1221\u20131226.","journal-title":"Cancer Treat Rep"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1664"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013777"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.08.026"},{"key":"e_1_3_3_15_2","first-page":"33","article-title":"Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.","volume":"53","author":"Di Marco A","year":"1969","unstructured":"Di Marco A, Gaetani M, Scarpinato B. Adriamycin (NSC-123,127): a new antibiotic with antitumor activity. Cancer Chemother Rep. 1969;53:33\u201337.","journal-title":"Cancer Chemother Rep"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197307)32:1<1::aid-cncr2820320101>3.0.co;2-x"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-80-2-249"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.4.724"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.12.2385"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70063-4"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30622-8"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0439-8"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.50"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30191"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00587-9"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197507)36:1<90::aid-cncr2820360104>3.0.co;2-h"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/90.16.1205"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.02.063"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-0442"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)00285-4"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2002-0013"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01374"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6041"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90601-S"},{"key":"e_1_3_3_35_2","first-page":"1503","article-title":"Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma.","volume":"21","author":"Ning YM","year":"2007","unstructured":"Ning YM, He K, Dagher R, Sridhara R, Farrell AT, Justice R, Pazdur R. Liposomal doxorubicin in combination with bortezomib for relapsed or refractory multiple myeloma. Oncology (Williston Park). 2007;21:1503\u20138; discussion 1511, 1513, 1516 passim.","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.7519"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.307"},{"key":"e_1_3_3_38_2","first-page":"955","article-title":"Necropsy study of 4 patients treated with rubidomycin.","volume":"15","author":"Ripault J","year":"1967","unstructured":"Ripault J, Weil M, Jacquillat C. Necropsy study of 4 patients treated with rubidomycin. Pathol Biol. 1967;15:955\u2013957.","journal-title":"Pathol Biol"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.31.5.607"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1967)20:3<333::aid-cncr2820200302>3.0.co;2-k"},{"key":"e_1_3_3_41_2","first-page":"949","article-title":"Cardiac complications observed during treatment with rubidomycin.","volume":"15","author":"Macrez C","year":"1967","unstructured":"Macrez C, Marneffe-Lebrequier H, Ripault J, Clauvel JP, Jacquillat C, Weil M. Cardiac complications observed during treatment with rubidomycin. Pathol Biol. 1967;15:949\u2013953.","journal-title":"Pathol Biol"},{"key":"e_1_3_3_42_2","first-page":"2572","article-title":"Phase I and preliminary phase II evaluation of adriamycin (NSC 123127).","volume":"30","author":"Bonadonna G","year":"1970","unstructured":"Bonadonna G, Monfardini S, De Lena M, Fossati-Bellani F, Beretta G. Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). Cancer Res. 1970;30:2572\u20132582.","journal-title":"Cancer Res"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1971)28:4<844::aid-cncr2820280407>3.0.co;2-9"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(69)92093-5"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11407"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-5-710"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103213241205"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz766"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.02.050"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeac106"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32833ffb56"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.15.162"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.576850"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1040-8428(97)10007-5"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00026"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0500"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-01996-6"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2024.07.002"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.07.018"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00394.2018"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00370.2019"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.06.005"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2023.107195"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108116"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8527"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015598"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijchy.2021.100085"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-021-02825-1"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.121.316697"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41514-024-00135-7"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.016"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/RES.0000000000000473"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add4920"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6093249"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2919"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-842"},{"key":"e_1_3_3_79_2","first-page":"460","article-title":"Effect of anthracycline antibiotics on oxygen radical formation in rat heart.","volume":"43","author":"Doroshow JH","year":"1983","unstructured":"Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 1983;43:460\u2013472.","journal-title":"Cancer Res"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1734-1140(09)70018-0"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-10-2664"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(84)90380-8"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0301-4622(90)80012-v"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-409x(01)00128-4"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.242"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.1994.1246"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1006\/taap.2001.9230"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.1996.0095"},{"key":"e_1_3_3_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)35747-2"},{"key":"e_1_3_3_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)35746-0"},{"key":"e_1_3_3_91_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00073.2019"},{"key":"e_1_3_3_92_2","doi-asserted-by":"publisher","DOI":"10.1002\/aac2.12033"},{"key":"e_1_3_3_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2019.05.016"},{"key":"e_1_3_3_94_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062814"},{"key":"e_1_3_3_95_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.021774"},{"key":"e_1_3_3_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4554-4"},{"key":"e_1_3_3_97_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3499-9"},{"key":"e_1_3_3_98_2","doi-asserted-by":"publisher","DOI":"10.1177\/2047487318811181"},{"key":"e_1_3_3_99_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-022-07520-6"},{"key":"e_1_3_3_100_2","doi-asserted-by":"publisher","DOI":"10.3390\/nu16213777"},{"key":"e_1_3_3_101_2","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvad031"},{"key":"e_1_3_3_102_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.11887"},{"key":"e_1_3_3_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2014.08.009"},{"key":"e_1_3_3_104_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-195010000-00018"},{"key":"e_1_3_3_105_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1333648"},{"key":"e_1_3_3_106_2","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2009.10.5.425"},{"key":"e_1_3_3_107_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012757.pub2"},{"key":"e_1_3_3_108_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199901000-00009"},{"key":"e_1_3_3_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2021.05.032"},{"key":"e_1_3_3_110_2","first-page":"4339","article-title":"First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.","volume":"23","author":"Fiorentini G","year":"2003","unstructured":"Fiorentini G, Tsetis D, Bernardeschi P, Varveris C, Rossi S, Kalogeraki A, Athanasakis E, Dentico P, Kanellos P, Biancalani M, et al. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer. Anticancer Res. 2003;23:4339\u20134345.","journal-title":"Anticancer Res"},{"key":"e_1_3_3_111_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686060"},{"key":"e_1_3_3_112_2","first-page":"761","article-title":"Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer.","volume":"20","author":"Pacetti P","year":"2006","unstructured":"Pacetti P, Mambrini A, Paolucci R, Sanguinetti F, Palmieri B, Della Seta R, Muttini MP, Fiorentini G, Cantore M. Intra-arterial chemotherapy: a safe treatment for elderly patients with locally advanced breast cancer. In Vivo. 2006;20:761\u2013764.","journal-title":"In Vivo"},{"key":"e_1_3_3_113_2","first-page":"20","article-title":"Neoadjuvant intra-arterial chemotherapy in locally advanced breast cancer: a prospective randomized study. Osaka Breast Cancer Study Group.","volume":"24","author":"Takatsuka Y","year":"1994","unstructured":"Takatsuka Y, Yayoi E, Kobayashi T, Aikawa T, Kotsuma Y. Neoadjuvant intra-arterial chemotherapy in locally advanced breast cancer: a prospective randomized study. Osaka Breast Cancer Study Group. Jpn J Clin Oncol. 1994;24:20\u201325.","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_3_3_114_2","doi-asserted-by":"publisher","DOI":"10.2478\/v10019-011-0014-7"},{"key":"e_1_3_3_115_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1197424"},{"key":"e_1_3_3_116_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008335331516"},{"key":"e_1_3_3_117_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040847"},{"key":"e_1_3_3_118_2","doi-asserted-by":"publisher","DOI":"10.1159\/000282325"},{"key":"e_1_3_3_119_2","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.185.3.1438780"},{"key":"e_1_3_3_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2013.05.065"},{"key":"e_1_3_3_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.04.006"},{"key":"e_1_3_3_122_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24916"},{"key":"e_1_3_3_123_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24023"},{"key":"e_1_3_3_124_2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000931"},{"key":"e_1_3_3_125_2","first-page":"487","article-title":"Doxorubicin (75 mg\/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results.","volume":"68","author":"Chlebowski RT","year":"1984","unstructured":"Chlebowski RT, Brzechwa-Adjukiewicz A, Cowden A, Block JB, Tong M, Chan KK. Doxorubicin (75 mg\/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. Cancer Treat Rep. 1984;68:487\u2013491.","journal-title":"Cancer Treat Rep"},{"key":"e_1_3_3_126_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50047"},{"key":"e_1_3_3_127_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08649-X"},{"key":"e_1_3_3_128_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(90)90220-l"},{"key":"e_1_3_3_129_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.2792"},{"key":"e_1_3_3_130_2","doi-asserted-by":"publisher","DOI":"10.21037\/atm-2020-131"},{"key":"e_1_3_3_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.2008.00984.x"},{"key":"e_1_3_3_132_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1443-9573.2006.00243.x"},{"key":"e_1_3_3_133_2","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.122.000425"},{"key":"e_1_3_3_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.01.022"},{"key":"e_1_3_3_135_2","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2020.20.e40"},{"key":"e_1_3_3_136_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00608"},{"key":"e_1_3_3_137_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.03.005"},{"key":"e_1_3_3_138_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2023.101300"},{"key":"e_1_3_3_139_2","doi-asserted-by":"publisher","DOI":"10.1177\/1758835918780140"},{"key":"e_1_3_3_140_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_3_141_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_3_3_142_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2024.103182"},{"key":"e_1_3_3_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.liver.2021.100063"},{"key":"e_1_3_3_144_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4379"},{"key":"e_1_3_3_145_2","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v16.i3.844"},{"key":"e_1_3_3_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9610(98)00042-7"},{"key":"e_1_3_3_147_2","doi-asserted-by":"publisher","DOI":"10.1016\/s1051-0443(07)61789-8"},{"key":"e_1_3_3_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0720-048x(01)00417-x"},{"key":"e_1_3_3_149_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869709001304"},{"key":"e_1_3_3_150_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2011.10.008"},{"key":"e_1_3_3_151_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(91)90873-a"},{"key":"e_1_3_3_152_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00193"},{"key":"e_1_3_3_153_2","doi-asserted-by":"publisher","DOI":"10.1002\/wnan.1364"},{"key":"e_1_3_3_154_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114525"},{"key":"e_1_3_3_155_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0008"},{"key":"e_1_3_3_156_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153741"},{"key":"e_1_3_3_157_2","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.","volume":"54","author":"Gabizon A","year":"1994","unstructured":"Gabizon A, Catane R, Uziely B, Kaufman B, Safra T, Cohen R, Martin F, Huang A, Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 1994;54:987\u2013992.","journal-title":"Cancer Res"},{"key":"e_1_3_3_158_2","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.2000.1459"},{"key":"e_1_3_3_159_2","doi-asserted-by":"publisher","DOI":"10.1080\/028418600430789"},{"key":"e_1_3_3_160_2","doi-asserted-by":"publisher","DOI":"10.7150\/thno.3463"},{"key":"e_1_3_3_161_2","doi-asserted-by":"publisher","DOI":"10.3816\/cbc.2003.n.037"},{"key":"e_1_3_3_162_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10201"},{"key":"e_1_3_3_163_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.5.1444"},{"key":"e_1_3_3_164_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh097"},{"key":"e_1_3_3_165_2","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.746114"},{"key":"e_1_3_3_166_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh393"},{"key":"e_1_3_3_167_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.027862"},{"key":"e_1_3_3_168_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.21522"},{"key":"e_1_3_3_169_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12439"},{"key":"e_1_3_3_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.05.013"},{"key":"e_1_3_3_171_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841860600693473"},{"key":"e_1_3_3_172_2","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008386822906"},{"key":"e_1_3_3_173_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.10.020"},{"key":"e_1_3_3_174_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-009-9711-7"},{"key":"e_1_3_3_175_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.199"},{"key":"e_1_3_3_176_2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2017.0177"},{"key":"e_1_3_3_177_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.7.2445"},{"key":"e_1_3_3_178_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.8.2353"},{"key":"e_1_3_3_179_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.653"},{"key":"e_1_3_3_180_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-025-00375-w"},{"key":"e_1_3_3_181_2","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf101"},{"key":"e_1_3_3_182_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000130926.51766.CC"},{"key":"e_1_3_3_183_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(00)00748-8"},{"key":"e_1_3_3_184_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030893"},{"key":"e_1_3_3_185_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0235-2"},{"key":"e_1_3_3_186_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70476-X"},{"key":"e_1_3_3_187_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30950-z"},{"key":"e_1_3_3_188_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113365"},{"key":"e_1_3_3_189_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01522-4"},{"key":"e_1_3_3_190_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00157-8"},{"key":"e_1_3_3_191_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.042"},{"key":"e_1_3_3_192_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.03.006"},{"key":"e_1_3_3_193_2","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S220740"},{"key":"e_1_3_3_194_2","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00266.2016"},{"key":"e_1_3_3_195_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14204"},{"key":"e_1_3_3_196_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41684-024-01377-4"},{"key":"e_1_3_3_197_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2024.07.012"},{"key":"e_1_3_3_198_2","doi-asserted-by":"publisher","DOI":"10.1161\/RES.0000000000000291"},{"key":"e_1_3_3_199_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-023-09835-4"},{"key":"e_1_3_3_200_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2022.04.003"},{"key":"e_1_3_3_201_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2675"},{"key":"e_1_3_3_202_2","first-page":"196","article-title":"Doxorubicin cardiotoxicity in African Americans.","volume":"96","author":"Hasan S","year":"2004","unstructured":"Hasan S, Dinh K, Lombardo F, Kark J. Doxorubicin cardiotoxicity in African Americans. J Natl Med Assoc. 2004;96:196\u2013199.","journal-title":"J Natl Med Assoc"},{"key":"e_1_3_3_203_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2021.05.001"},{"key":"e_1_3_3_204_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.037780"},{"key":"e_1_3_3_205_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-018-0198-2"},{"key":"e_1_3_3_206_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506293322602"},{"key":"e_1_3_3_207_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.033"},{"key":"e_1_3_3_208_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.1242"},{"key":"e_1_3_3_209_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319901"},{"key":"e_1_3_3_210_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2014.07.012"},{"key":"e_1_3_3_211_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccao.2020.10.011"},{"key":"e_1_3_3_212_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.70005"},{"key":"e_1_3_3_213_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gerinurse.2025.103716"},{"key":"e_1_3_3_214_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034646"},{"key":"e_1_3_3_215_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.194316"},{"key":"e_1_3_3_216_2","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12625"},{"key":"e_1_3_3_217_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40959-021-00104-z"},{"key":"e_1_3_3_218_2","first-page":"87","article-title":"A method for detection of doxorubicin-induced cardiotoxicity: flow-mediated vasodilation of the brachial artery.","volume":"6","author":"Nagy L","year":"2001","unstructured":"Nagy L, Szab\u00f3 F, Iv\u00e1nyi J, N\u00e9meth L, Kov\u00e1cs GL, Palatka J, Tarj\u00e1n J, T\u00f3th K, Roth E. A method for detection of doxorubicin-induced cardiotoxicity: flow-mediated vasodilation of the brachial artery. Exp Clin Cardiol. 2001;6:87\u201392.","journal-title":"Exp Clin Cardiol"},{"key":"e_1_3_3_219_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-025-09986-2"},{"key":"e_1_3_3_220_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab053"},{"key":"e_1_3_3_221_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-012-9590-1"},{"key":"e_1_3_3_222_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2018.11.036"},{"key":"e_1_3_3_223_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12881"},{"key":"e_1_3_3_224_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2024.06.002"},{"key":"e_1_3_3_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.09.1140"}],"container-title":["Arteriosclerosis, Thrombosis, and Vascular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/ATVBAHA.125.319865","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:57:38Z","timestamp":1785520658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/ATVBAHA.125.319865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":224,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1161\/ATVBAHA.125.319865"],"URL":"https:\/\/doi.org\/10.1161\/atvbaha.125.319865","relation":{},"ISSN":["1079-5642","1524-4636"],"issn-type":[{"value":"1079-5642","type":"print"},{"value":"1524-4636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"2026-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}